V. Iranzo González-Cruz

Management of malignant insulinoma

J. C. Ferrer-García, C. Morillas-Ariño, V. Iranzo González-Cruz, 2013, Clinical and Translational Oncology.

Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer

V. Iranzo González-Cruz, C. Camps Herrero, S. Calabuig-Fariñas, 2022, Cancers.

SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients (2021)

X. Mielgo-Rubio, V. Iranzo González-Cruz, I. Echavarria, 2022, Clinical and Translational Oncology.

Update on systemic treatment in early triple negative breast cancer

V. Iranzo González-Cruz, C. Camps Herrero, S. Calabuig-Fariñas, 2021, Therapeutic advances in medical oncology.

Some reflexions on the modified Appleby procedure.

V. Iranzo González-Cruz, F. Morera-Ocón, Inmaculada Cárcel-Cárcel, 2009, JOP : Journal of the pancreas.